MiR-34-a acts as a suppressor in neuroblastoma progression by targeting CD44.
Year: 2017
Type: article
Source: PubMed
Authors: Jiang Chen, Lu Hongting, Lv Shaoping, Chen Xin, Dong Qian
Institution: Affiliated Hospital of Qingdao University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2798024247
